학술논문
Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer.
Document Type
Article
Author
Chan, Arlene; Ruiz-Borrego, Manuel; Marx, Gavin; Chien, A. Jo; Rugo, Hope S.; Brufsky, Adam; Thirlwell, Michael; Trudeau, Maureen; Bose, Ron; García-Sáenz, José A.; Egle, Daniel; Pistilli, Barbara; Wassermann, Johanna; Cheong, Kerry A.; Schnappauf, Benjamin; Semsek, Dieter; Singer, Christian F.; Foruzan, Navid; DiPrimeo, Daniel; McCulloch, Leanne
Source
Breast; Feb2023, Vol. 67, p94-101, 8p
Subject
Language
ISSN
09609776
Abstract
Copyright of Breast is the property of Churchill Livingstone, Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)